As gut microbiota alterations have been reported for animal models of both lack [10] or hyperactivation [35] of NLRP3, the question arises, whether NLRP3 variant induced modulation of the gut microbiota might be involved in the effect on IBD disease course. Here, NLRP3 is linked to inflammatory bowel disease.